Cannabis Shows Promise for Migraine Relief: UK Study Insights
- 3 hours ago
- 1 min read
Research Summary
A study published in Brain and Behavior explored the effects of cannabis-based medicinal products (CBMPs) on migraines, revealing promising results. Researchers analyzed data from the UK Medical Cannabis Registry involving 203 adults. CBMPs showed significant improvements in headache impact, anxiety, sleep quality, and overall health-related quality of life up to 24 months. Notably, migraine disability improved up to 12 months. However, female patients and those with lower THC doses showed less improvement. Adverse events were reported by 15% of participants, mostly mild to moderate. While CBMPs appear beneficial, further randomized controlled trials are necessary to confirm these findings.
Study Details
👥 Research Team: Hooper L et al.
📚 Published In: Brain Behav
📅 Publication Date: 2026 Apr
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.